Early Clinical Trials Services

From promising compound to clinical breakthrough, getting you to first-in-human and proof-of-concept clinical studies. Explore clinical pharmacology services.
2024 Fierce CRO Awards
Quotient Sciences has been recognized as a winner of the 2024 Fierce CRO Awards category for "Innovative Solutions in Drug Development."
The path to proof-of-concept patient studies
Quotient Sciences provide the expertise, infrastructure, and agility to move your novel therapy forward, faster, whether you are looking to reach first-in-human trials or bridge later into proof-of-concept clinical testing.

Proven expertise for your FIH and POC trials

Conducted with speed, safety, and certainty, our early phase clinical trials involve healthy volunteers and can extend to a variety of special populations and patient groups across all therapeutic areas. 

Biomarkers & Pharmacodynamic Assessments:

  • Cardiac telemetry
  • Holter monitoring (and QTc analysis)
  • Laboratory biomarkers (incl. preparation of PBMCs)
  • CSF sampling
  • Pulmonary function testing
  • Taste assessments
  • Sleep, neurological and EEG assessments
  • Scales and ratings (e.g. visual analogue scales, diaries)
  • Opthalmologic assessments
  • Mixed meal tolerance test/Oral glucose tolerance test
  • Quantitative food intake assessements
  • Genotyping
  • Skin assessments (incl. digital photography and biopsy) 

Therapeutic Areas:

  • Cardiovascular
  • Dermatology
  • Endocrinology & Metabolic
  • Gastrotenterology
  • Haematology & Immunology
  • Hepatology
  • Infectious disease
  • Muscoskeletal
  • Nephrology & Urology
  • Neurology & CNS
  • Opthalmology
  • Psychiatry
  • Pulmonary & Respiratory
  • Reproductive & Women's Health
  • Rheumatology
  • Rare & orphan diseases
  • and more 

Populations:

  • Healthy volunteers
  • Healthy elderly
  • Post-menopausal women
  • Women taking oral contraception
  • Men and women of non-child-bearing potential
  • Otherwise healthy obese
  • Healthy smokers
  • Japanese and Chinese

Patient populations can be recruited via direct advertising or in collaboration with specialists. For example, our partnership with Biorasi combines Quotient Sciences’ expertise in early clinical development with Biorasi’s global patient recruitment capabilities, for a simplified path from IND to POC. Learn more >

Get in touch
Humanity can't afford to wait, so neither can we.